Lockheed Martin
LMT
505.50
+6.28
+1.26%
Lockheed Martin
US · LMT
#169 by market cap
Listed 1970
505.50
+6.28
+1.26%
Live - 5344 symbols - heartbeat 210s ago
· 2026-10-08 10:09
Pre-market
499.50
+0.06%
After-hours
500.39
+0.23%
Overnight
499.22
0.00%
- Market cap
- 116.66B
- P/E (TTM)i
- 18.64
- P/Bi
- 13.31
- EPSi
- 21.49
- Div yieldi
- 2.70%
- 52W posi
- 30%
Reader sentiment
Are you bullish or bearish on LMT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.37, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +5.64% YoY
Margins
- Gross margin
- 10.15%
- Operating margin
- 10.30%
- Net margin
- 6.69%
Key ratios & quality
- Enterprise valuei
- 134.24B
- Altman Z-Scorei
- 3.37
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 53.76B | 59.81B | 65.40B | 67.04B | 65.98B | 67.57B | 71.04B | 75.05B |
| Gross profit | 7.27B | 8.37B | 8.65B | 9.06B | 8.29B | 8.48B | 6.93B | 7.62B |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 7.33B | 8.55B | 8.64B | 9.12B | 8.35B | 8.51B | 7.01B | 7.73B |
| Pretax profit | 5.84B | 7.24B | 8.24B | 7.55B | 6.68B | 8.10B | 6.22B | 5.92B |
| Tax | 792.00M | 1.01B | 1.35B | 1.24B | 948.00M | 1.18B | 884.00M | 905.00M |
| Net profit | 5.05B | 6.23B | 6.83B | 6.32B | 5.73B | 6.92B | 5.34B | 5.02B |
| Basic EPS | 18 | 22 | 24 | 23 | 22 | 28 | 22 | 22 |
| Diluted EPS | 17.59 | 21.95 | 24.30 | 22.76 | 21.66 | 27.55 | 22.31 | 21.49 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 17.96B | 18.16B | 18.61B | 20.32B | 18.02B | 20.06B |
| Gross profit | 2.32B | 734.00M | 2.24B | 2.32B | 2.08B | 2.45B |
| Selling & admin expenses | -- | 99.00M | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 2.37B | 748.00M | 2.28B | 2.33B | 2.06B | 2.48B |
| Pretax profit | 2.04B | 417.00M | 1.94B | 1.53B | 1.77B | 2.18B |
| Tax | 324.00M | 75.00M | 319.00M | 187.00M | 286.00M | 342.00M |
| Net profit | 1.71B | 342.00M | 1.62B | 1.34B | 1.49B | 1.84B |
| Basic EPS | 7 | 1 | 7 | 6 | 6 | 8 |
| Diluted EPS | 7.28 | 1.46 | 6.95 | 5.80 | 6.44 | 7.94 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 16.10B | 17.10B | 19.38B | 19.82B | 20.99B | 20.52B | 21.85B | 25.36B |
| Cash & ST investments | 772.00M | 1.51B | 3.16B | 3.60B | 2.55B | 1.44B | 2.48B | 4.12B |
| Inventory | 3.00B | 3.62B | 3.55B | 2.98B | 3.09B | 3.13B | 3.47B | 3.52B |
| Total assets | 44.88B | 47.53B | 50.71B | 50.87B | 52.88B | 52.46B | 55.62B | 59.84B |
| Total current liabilities | 14.40B | 13.97B | 13.93B | 14.00B | 15.89B | 16.94B | 19.42B | 23.34B |
| Short-term debt | 1.50B | 1.25B | 500.00M | -- | 118.00M | 168.00M | 643.00M | 1.17B |
| Long-term debt | 12.60B | 11.40B | 11.67B | 11.67B | 15.43B | 17.29B | 19.63B | 20.53B |
| Total liabilities | 43,427,000,000.00 | 44,357,000,000.00 | 44,672,000,000.00 | 39,914,000,000.00 | 43,614,000,000.00 | 45,621,000,000.00 | 49,284,000,000.00 | 53,119,000,000.00 |
| Total equity | 1.45B | 3.17B | 6.04B | 10.96B | 9.27B | 6.84B | 6.33B | 6.72B |
| Retained earnings | 15.43B | 18.40B | 21.64B | 21.60B | 16.94B | 15.40B | 14.55B | 14.03B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 22.80B | 23.99B | 25.94B | 25.36B | 25.08B | 28.40B |
| Cash & ST investments | 1.80B | 1.29B | 3.47B | 4.12B | 1.89B | 3.79B |
| Inventory | 3.60B | 3.70B | 3.75B | 3.52B | 4.25B | 4.41B |
| Total assets | 56.67B | 58.87B | 60.28B | 59.84B | 59.24B | 62.45B |
| Total current liabilities | 21.19B | 24.35B | 22.97B | 23.34B | 22.09B | 23.81B |
| Short-term debt | 1.64B | 3.12B | 1.67B | 1.17B | 168.00M | -- |
| Long-term debt | 18.66B | 18.52B | 20.52B | 20.53B | 20.53B | 20.54B |
| Total liabilities | 49,986,000,000.00 | 53,536,000,000.00 | 54,095,000,000.00 | 53,119,000,000.00 | 51,749,000,000.00 | 53,682,000,000.00 |
| Total equity | 6.68B | 5.33B | 6.18B | 6.72B | 7.49B | 8.77B |
| Retained earnings | 14.77B | 13.26B | 14.05B | 14.03B | 14.72B | 15.76B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 3.14B | 7.31B | 8.18B | 9.22B | 7.80B | 7.92B | 6.97B | 8.56B |
| Depreciation & amortization | 1.16B | 1.19B | 1.29B | 1.36B | 1.40B | 1.43B | 1.56B | 1.69B |
| Free cash flow | 1.86B | 5.83B | 6.42B | 7.70B | 6.13B | 6.23B | 5.29B | 6.91B |
| Dividends paid | -2.35B | -2.56B | -2.76B | -2.94B | -3.02B | -3.06B | -3.06B | -3.13B |
| Stock buybacks / issuance | -1.49B | -1.20B | -1.10B | -4.09B | -7.90B | -6.00B | -3.70B | -3.00B |
| Ending cash balance | 772.00M | 1.51B | 3.16B | 3.60B | 2.55B | 1.44B | 2.48B | 4.12B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.41B | 201.00M | 3.73B | 3.22B | 220.00M | 3.24B |
| Depreciation & amortization | 397.00M | 399.00M | 428.00M | 463.00M | 398.00M | 400.00M |
| Free cash flow | 955.00M | -150.00M | 3.35B | 2.76B | -291.00M | 2.92B |
| Dividends paid | -796.00M | -771.00M | -765.00M | -799.00M | -816.00M | -796.00M |
| Stock buybacks / issuance | -750.00M | -500.00M | -1.00B | -750.00M | 0 | 0 |
| Ending cash balance | 1.80B | 1.29B | 3.47B | 4.12B | 1.89B | 3.79B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 1,419.41 | 275.60 | 149.49 | 74.41 | 56.68 | 85.96 | 81.05 | 76.87 |
| ROA %i | 11.04 | 13.48 | 13.91 | 12.43 | 11.05 | 13.14 | 9.87 | 8.69 |
| ROIC %i | 38.68 | 43.43 | 43.14 | 33.27 | 26.48 | 31.34 | 24.46 | 21.68 |
| 5-year avg ROE %i | 574.30 | 612.04 | 619.74 | 589.72 | 482.27 | 128.43 | 89.52 | 74.99 |
| EBIT margin %i | 12.10 | 13.20 | 13.50 | 12.11 | 11.07 | 13.34 | 10.21 | 9.38 |
| FCF / sales %i | 3.46 | 9.74 | 9.81 | 11.48 | 9.29 | 9.22 | 7.44 | 9.20 |
| Current ratioi | 1.12 | 1.22 | 1.39 | 1.42 | 1.32 | 1.21 | 1.13 | 1.09 |
| Quick ratioi | 0.88 | 0.93 | 1.05 | 1.15 | 1.09 | 0.99 | 0.92 | 0.90 |
| Debt / assetsi | 31.43 | 26.62 | 24.00 | 22.94 | 29.40 | 33.28 | 36.45 | 36.26 |
| LT debt / equityi | 904.16 | 364.69 | 194.00 | 106.49 | 166.51 | 252.98 | 309.92 | 305.49 |
| Interest coveragei | 9.74 | 12.09 | 14.93 | 14.27 | 11.72 | 9.84 | 7.00 | 6.30 |
| Revenue CAGR (3Y) %i | 9.87 | 8.15 | 9.39 | 7.64 | 3.33 | 1.10 | 1.95 | 4.38 |
| Net income CAGR (3Y) %i | 11.86 | 6.39 | 51.55 | 7.76 | -2.74 | 0.42 | -5.46 | -4.34 |
| FCF CAGR (3Y) %i | -23.55 | 12.19 | 6.59 | 60.56 | 1.72 | -0.99 | -11.78 | 4.05 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 82.55 | 73.06 | 62.78 | 76.87 | 67.64 | 89.16 |
| ROA %i | 9.86 | 7.38 | 7.25 | 8.69 | 8.27 | 10.36 |
| ROIC %i | 24.13 | 19.53 | 18.71 | 21.68 | 20.81 | 27.19 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 10.40 | 8.28 | 8.18 | 9.38 | 9.03 | 11.08 |
| FCF / sales %i | 6.94 | 4.63 | 6.26 | 9.20 | 7.54 | 11.33 |
| Current ratioi | 1.08 | 0.98 | 1.13 | 1.09 | 1.14 | 1.19 |
| Quick ratioi | 0.87 | 0.80 | 0.93 | 0.90 | 0.91 | 0.97 |
| Debt / assetsi | 35.83 | 36.76 | 36.81 | 36.26 | 34.94 | 32.89 |
| LT debt / equityi | 279.23 | 347.21 | 331.99 | 305.49 | 274.12 | 234.24 |
| Interest coveragei | 7.12 | 5.60 | 5.50 | 6.30 | 6.06 | 7.68 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Aeronautics is the largest reported line at 40.99% of revenue, across 5 reported segments.
- No single line clears half of revenue; Rotary and Mission Systems (RMS) is next at 25.00%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Aeronautics40.99%
Rotary and Mission Systems (RMS)25.00%
Missiles and Fire Control (MFC)21.70%
Space17.82%
Quote time 2026-10-08 10:09:53 · For reference only, not investment advice and not tailored to your situation.